Podcasts about The Texas Heart Institute

Steven K. Scott is the founder of Biotech Nutritional Sciences, Neumi Inc., and co-founder of American Telecast Corp, Total Gym Fitness, and numerous other companies. He is also a NY Times best-selling author of fifteen books. His privately held companies have achieved billions of dollars in sales. He has appeared in hundreds of radio and television interviews, including repeat appearances on Larry King Live, Fox and Friends and various Christian television shows including, 700 Club, TBN's Praise, Life Today, Daystar, and many others. Steve's latest company, Biotech Nutritional Sciences (BNS) has created a breakthrough technology for the molecular encapsulation of biologics including glutathione, l-cysteine, and other peptides and nutrients. BNS's Hydrastat Molecular Encapsulation™ delivery system has achieved levels of bioavailability and cellular utilization of peptides and nutrients never before seen. The resulting outcomes in supporting health and human performance have been extraordinary. Athletes are performing at career-high levels and have broken world records. The medical and non-medical applications of this technology cover a wide spectrum of applications for every tissue, muscle, organ, and mitochondrial function. After only three years in the marketplace, BNS's life-changing products are now distributed in more than 70 countries. BNS's unpaid medical advisory board includes world-renowned physicians from Harvard, the Mayo Clinic, Stanford, Baylor's Texas Heart Institute, and many other renowned medical institutions. These doctors and medical researchers have seen the unparalleled outcomes this of novel technology and they share Scott's vision for providing these products to people in every country in the world. Contact Steven K. Scott: Website: SteveKscott.com Books: The Joseph Principals – turning adversity and heartache into miraculous living. The Greatest Words Ever Spoken Jesus Speaks The Richest Man Who Ever Lived – king Solomon's secrets to success, wealth and happiness. Simple Steps to Impossible Dreams Mentored by a Millionaire- The master strategies of super achievers. A Millionaire's Notebook – how ordinary people achieve extraordinary success. The Greatest Man Who Ever Lived Neumi: https://neumi.com/incrediblelife Dr. Kimberley Linert Speaker, Author, Broadcaster, Mentor, Trainer, Behavioral Optometrist Event Planners- I am available to speak at your event. Here is my media kit: https://brucemerrinscelebrityspeakers.com/portfolio/dr-kimberley-linert/ To book Dr. Linert on your podcast, television show, conference, corporate training or as an expert guest please email her at incrediblelifepodcast@gmail.com or Contact Bruce Merrin at Bruce Merrin's Celebrity Speakers at merrinpr@gmail.com 702.256.9199 Host of the Podcast Series: Incredible Life Creator Podcast Available on... Apple: https://podcasts.apple.com/us/podcast/incredible-life-creator-with-dr-kimberley-linert/id1472641267 Spotify: https://open.spotify.com/show/6DZE3EoHfhgcmSkxY1CvKf?si=ebe71549e7474663 and on 9 other podcast platforms Author of Book: "Visualizing Happiness in Every Area of Your Life" Get on Amazon: https://amzn.to/3srh6tZ Website: https://www.DrKimberleyLinert.com Please subscribe, share & LISTEN! Thanks. incrediblelifepodcast@gmail.com Social Media Links LinkedIn: https://www.linkedin.com/in/dr-kimberley-linert-incredible-life-creator/ Facebook: https://www.facebook.com/kimberley.linert/ The Great Discovery eLearning Platform: https://thegreatdiscovery.com/kimberley l

A new feature of our weekly newsletter is to ask experts in the field of medicine and healthcare three questions in their field of specialty. This week we have Dr. Joseph Rogers, a world renowned cardiologist and medical director of the Texas Heart Institute in the world famous Texas Medical Center, here in Houston, Texas.The three questions that we proposed to Dr. Rogers included:(1) His thoughts on Home blood pressure monitoring for those that already have a diagnosis of high blood pressure or those that don't have high blood pressure and or simply interested in their health?(2) Dietary supplements and their claims to lower blood pressure-any value?(3) The third question was on sleep apnea and its impact on cardiovascular disease?We plan on having these brief conversations in each of our newsletters, helping our followers become better consumers of healthcare, and raising your health IQ. If you are not a subscriber to our weekly newsletter, which goes out every Saturday morning. Follow the link below to sign up and never miss an issue.Newsletter signup linkFollow Dr. Galati Online Hosted on Acast. See acast.com/privacy for more information.

In this special episode of JHLT: The Podcast, the Digital Media Editors connect with Joseph Rogers, MD, the new Editor-in-Chief of JHLT. In the conversation, Dr. Rogers shares more about his vision for the Journal, how he plans to tackle the challenges and opportunities facing the publication, and a little about his life both inside and outside of medicine. In addition to being the new Editor-in-Chief, Dr. Rogers is the President and CEO of the Texas Heart Institute in Houston, a past president of the ISHLT, and a prolific contributor to the field of heart and lung transplantation. For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

Dr. William E. Cohn is a leader in cardiovascular surgery and medical device innovation here in Houston. Dr. Cohn shares a bit about his role as director of the Center for Device Innovation at the Texas Medical Center as well as his experience as chief medical officer of BiVACOR, a unique medical device company that has created a total artificial heart that Dr. Cohn expects to revolutionize heart transplants.

Wes, Eneasz, and David keep the rationalist community informed about what's going on outside of the rationalist communitySupport us on Substack!News discussed:There was a Biden vs Lettuce! The Lettuce won.CrowdStrike Falcon is endpoint monitoring software. (doesn't just protect from malicious code, also tracks assets). Reminder: Any time you have auto-update enabled for anything, you have installed a free backdoorThe UBI experiment actually showed a lot of major upsides! Increased entrepreneurship, people held out longer for better jobs (which contributed to the lower employment number!), young people got more edu and single parents did more child raising, people were able to leave abusive relationships. Looking at naive averages isn't that useful. (also AskWhoCastsAI is one of my fav podcasts)The World Central Kitchen fuckup has been investigated. “An Australian review into the deaths said the Israel Defense Forces (IDF) decided to launch missiles at the convoy after mistakenly believing it was being hijacked by Hamas”Leaked Zoom recording of white house staff & DNC discussing how to best censor reports of Biden's mental decline. Most interesting part is how polite the threats are. Stuff like ‘you say you're reducing disinformation, but it looks like this disinformation about Biden's decline is still up on facebook. I'm not sure that's what reduction looks like'. Feels like Reality Is Becoming Impossible To SatirizeUS recognizes challenger as winner as riots continue in Venezuela  Hamas political leader Ismail Haniyeh killed by detonating a bomb planted in advance in his bedroom at the Iranian government official residenceIran vows major counterstrikes on the 12thHamas names a top architect of the Oct 7 terror rampage as new leader Hezbollah top commander Fouad Shukur (behind recent rocket attack in Isreal) killed by airstrike in Lebanontop Hamas military leader Mohammed Deif killed in GazaDays of riots in Britain. Backlash against immigration and perceived rise in crime. Best way to fix that is always beating up innocent minorities and destroying local businesses.Walz!Google lost antitrust suitTwitter files antitrust lawsuit against GARM. Sounds like BS lawsuit, but GARM does legit threaten corps that advertise on media outlets that they want to destroy with standard “shame if your store burned down” mob tactics. Much like patent trolls what they do is legal but should get them jail/confiscation/blinding. Russian prisoner exchange. The tween & teen kids of a spy couple discover they're Russian on the flight over to Russia.MegaQuake advisory in Japan In Bangladesh a government job quota system favoring the in-group sparked weeks of deadly riots (after over a decade of ratcheting authoritarianism and economic issues). Finally the prime minister fled the country after protestors stormed her residence, the president dissolved parliament, and the military is forming an interim govt.BAGUETTE NEWS! Frenchman's Giant Baguette is his undoing at the pole vault. (is offered $250k porn deal??) Joins acapella group.More top people leave Open AI - cofounder John Schulman leaves to join Anthropic, president Greg Brockman takes extended leave of absence, a VP resigns.accused 9/11 mastermind and two others gitmo got a plea deal, next day it was rescindedHappy News!“bridge editing” papers published in Nature promise more precise gene editing than CRISPR with fewer errors and disruptions.Nanofiber molecules cause human cartilage to begin regeneration process, which humans can't do in adulthood. Could lead to actual joint repair/regrowth. So far only on cell samples, not in humans.Texas Heart Institute implants the first Total Artificial Heart. Made of titanium and don't require anti-rejection medications. Uses rotary blood pump with a single moving part that utilizes a magnetically levitated rotor to greatly reduce friction and wear. Increases blood flow with demand to up to 12L/minute, allowing patients to exercise! Was only a place-holder for this surgery, but meant for long-term eventually. 3500 people on heart transplant list ATM.Australia begins campaign to eradicate peanut allergyTroop DeploymentEneasz -  Kamala Harris is The Mask That SmilesWes - Don't be a Baby About the ElectionGot something to say? Come chat with us on the Bayesian Conspiracy Discord or email us at themindkillerpodcast@gmail.com. Say something smart and we'll mention you on the next show!Follow us!RSS: http://feeds.feedburner.com/themindkillerGoogle: https://play.google.com/music/listen#/ps/Iqs7r7t6cdxw465zdulvwikhekmPocket Casts: https://pca.st/vvcmifu6 Stitcher: https://www.stitcher.com/podcast/the-mind-killer Apple: Intro/outro music: On Sale by Golden Duck Orchestra This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit mindkiller.substack.com/subscribe

This week, we're revisiting another enlightening chat with a Houston innovator. One year ago, Dr. Joseph Rogers, the president and CEO of Texas Heart Institute, shared his story and how he came to be at the helm of THI, as well as the incredible technologies the institute is working on to address heart failure, a global epidemic affecting at least 26 million people worldwide, 6.2 million adults in the U.S. This month, one of THI's technologies reached a major milestone. BiVACOR, a Houston company successfully implanted the company's first Total Artificial Heart in a human. In addition to this breakthrough in health tech, THI is focused on addressing Cardiometabolic Syndrome at a new conference on Friday, August 23, in Houston. The full-day symposium will take place in collaboration with Arianna Huffington, the founder and CEO of Thrive Global. Dr. Rogers is co-directing the program with Dr. Stephanie Coulter, medical director for THI Center for Women's Heart & Vascular Health.  Episode's original run date: July 26, 2023

On today's show, Dr. Galati gives guidelines on keeping a healthy cardiovascular system and talks about The Texas Heart Institute. Later, Dr. Galati revisits an old segment discussing college nutrition with his daughter Elizabeth.

Keri Sprung '22 is the vice president for education and director of the Women's Center at the Texas Heart Institute. She provides strategic direction to the physicians and scientists leading innovative research, education, and clinical programs at the Institute in partnership with regional, national, and international collaborators.During her studies at Rice, she served as the class representative, co-chair of the Rice Business Association for Executives, and a Rice Business Board Fellow for Children At Risk, a non-profit that serves as a catalyst for change to improve the quality of life for children through strategic research, and advocacy. Upon graduating from Rice Business, she was honored with the M.A. “Mike” Wright Award, the top leadership award. Host Maya Pomroy catches up with her friend and fellow '22 alum in this episode. Listen as they chat about their unforgettable Executive MBA cohort days, Keri's passion for healthcare and innovation, and the importance of finding good mentors. Owl Have You Know is a production of Rice Business and is produced by University FM.Episode Quotes:Cultivating growth with the Rice executive program19:25 - One of the shining parts of the Rice Program executive program is the leadership component, the leadership track. And I didn't even realize how committed Rice was to making sure this leadership and personal growth component was interlaced into really the entire journey of the 22 months. And so I grew as a leader. Not just from the material we were learning, but I think the interactions with our cohort and with our deans and professors. For me, I work in a medical community, and most of the leaders I'm around are doctors and scientists. So, it was really helpful for me to step out of the healthcare setting and to be around everybody who was a leader going into this program already but working on the different areas of their leadership. And it was really nice to learn from one another.What's next for Keri?29:38 - I wanted to make sure that I didn't just graduate and go back to my old ways. And so I've been mindful that I didn't expect to do this, but I started to engage with a startup nonprofit. One of the things I wanted to do was work with startups because I have a 360-degree view of innovation in medicine.The need for trust in Cohorts24:11 - The reality of business is that you're not doing this alone. Once you get to this level, you're not going to be a good leader if you can't motivate and work with different teams and disciplines.Embracing pivoting 5:28 - I realized that I embraced pivoting before pivoting was a trend post-COVID. So I decided to pivot, take my one exit from medicine, and go try to do some work in the real estate industry.Show Links:TranscriptGuest Profile:Keri Sprung - Texas Heart InstituteKeri Sprung - Rice BusinessKeri Sprung - Rice Business, Student FeatureKeri Sprung - LinkedIn

Cardiology fellow at the Texas Heart Institute, Matthew Segar, MD, MS talks about his research submission for the AMA Research Challenge: improving non-clinical tasks using a machine learning-enabled provider workflow. Find his poster here: https://www.ama-assn.org/system/files/matthew-segar-poster.pdf Learn more about the AMA Research Challenge here: https://www.ama-assn.org/about/events/ama-research-challenge-finals

Dr. Stephanie Coulter from Texas Heart Institute joined Dr. Joe Galati this week on the radio discussing heart health in women. Dr. Coulter is the Director of the Women's Center for Heart & Vascular Health, the Director of Cardiology Education, and the Program Director of the THI Cardiovascular Disease Fellowship. Links of Interest:Heart Health from Texas Heart InstituteBMI CalculatorKeeping Your Heart Healthy VideoWhere to find Dr. Joe Galati and his team:Dr. Galati's newsletter sign-upMedical Practice: Liver Specialists of TexasDr. Galati's Book Site: Eating Yourself SickFacebook: Dr. Joe GalatiDr. Galati's YouTube ChannelPlease send feedback and suggestion. You can message me here. Hosted on Acast. See acast.com/privacy for more information.

Dr. Galati is back in studio tonight to talk about heart disease. However, he starts by explaining the two lines he hears most from his patients. These are “let's watch it” and “let's keep an eye on it.” Dr. Stephanie Coulter of The Texas Heart Institute joins the program to talk all about heart disease in females.

How does an organization successfully go about launching a new and successful signature fundraising event after multi-year pause? Today, Rob talks with Texas Heart Institute's Vice President of Development Julie Voss as well as Kelli Kickerillo, who is a co-chair for The Supper Club, the organization's first signature fundraising event in 7 years. In this episode, Julie and Kelli share their thoughts on a variety of topics including tips on creating an innovative theme that intrigues and lures donors, forming a successful relationship between co-chairs and an organization's development team, and the one investment every organization should make for their gala or signature fundraising event.

CardioNerds cofounders Dr. Amit Goyal and Dr. Daniel Ambinder join Dr. Isabel Balachandran, Dr. Diego Celli from the Texas Heart Institute. They discuss the nuances of risk stratification management of intermediate risk pulmonary embolism. The ECPR for this episode was provided by Dr. Alam Mahboob (Associate Professor of Medicine at Baylor College of Medicine and the Department of Medicine and Associate Program Director for the Cardiovascular Disease Fellowship Program at Baylor). Audio editing by CardioNerds Academy Intern, Dr. Chelsea Amo Tweneboah. US Cardiology Review is now the official journal of CardioNerds! Submit your manuscript here. CardioNerds Case Reports PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Case Media - Caring for the Middle Child of Pulmonary Embolism – Texas Heart Institute Pearls - Caring for the Middle Child of Pulmonary Embolism – Texas Heart Institute Submassive pulmonary embolism is defined as an intermediate risk group of acute pulmonary embolism, which presents with signs of RV dysfunction and myocardial injury without hemodynamic instability. The AHA, ACCP, and ESC have variable definitions of submassive PE. Non-invasive tools such as EKG, TTE, and CT are critical to defining RV dysfunction. The Pulmonary Embolism Severity Index (PESI) score is a validated tool to help risk stratify patients with PE. Advanced therapies for submassive PE include systemic thrombolysis, catheter-based intervention, surgical embolectomy, and mechanical circulatory support. The decision between these therapies is based on individual patient risk profiles, local expertise, and the risk of major bleeding. There is a spectrum of long-term complications after an acute PE, ranging from post PE syndrome to CTEPH (chronic thromboembolic pulmonary hypertension) caused by a maladaptive vascular remodeling from residual thrombus or arteriopathy. Thrombolytic therapies are still controversial in reducing the risk of post PE complications. PERT is a multidisciplinary group of clinicians who can rapidly assess and triage patients with acute PE, coordinate access to medical and advanced therapies, and provide the necessary follow up care. Show Notes - Caring for the Middle Child of Pulmonary Embolism – Texas Heart Institute How do you define “submassive” pulmonary embolism? Venous thromboembolism, which includes deep vein thrombosis and acute pulmonary emboli (PE) are the third most common cardiovascular disorder in the United States with approximately 900,000 cases occurring each year (1). The morbidity and mortality associated with pulmonary emboli are also great, with approximately 33% of PE cases being fatal (1).Until recently, PE was previously classified into massive or non-massive. Massive PE was defined as those with cardiogenic shock. A newer group, “submassive PE”, was defined as an “intermediate” risk group. According to the American Heart Association (AHA) Scientific Statement on the management of massive and submassive PE, patients in this group presented with signs of RV dysfunction and myocardial necrosis without hemodynamic instability (2). Intermediate-risk PE covers a broad range of risk and management decisions remain challenging. Intermediate-risk PE convers increased risk for mortality and complications compared with low-risk PE.  How do you risk-stratify intermediate-risk pulmonary emboli? The AHA, American College of Chest Physicians (ACCP), and European Society of Cardiology (ESC) have variable definitions of submassive PE and which biomarkers should be used (1,3). The contents are summarized as below (Table 1) Each major guideline highlights the importance of the evaluation of RV dysfunction (RVD) and elevated biomarkers. To summarize,

Dr. Joseph Rogers is the president and CEO Texas Heart Institute. For over 60 years, THI has been a leader in cardiovascular health care and innovation. Around two years ago, Dr. Rogers took the helm of the organization and is particularly interested in preventative care. He shares more about THI and some of the innovative work its team is doing — from stem cell research to drug development and more — as well as the future of heart health.

Eddy Dacius hosts the Divine Purpose Podcast. DPPodcast is a platform for healthy conversations, interviews, and interactions with callers. We all have different opinions; however, the truth is the ultimate mediator. Clauden Louis. Cardiothoracic Surgery at Brigham and Women's Hospital Harvard University in Boston MA. I train in open and minimally invasive cardiac surgery. I love innovation and leadership. The cardiothoracic surgeons at the Texas Heart Institute and Baylor St. Luke's Medical Center in Houston recently hosted the 2022 American Association of Thoracic Surgery (AATS) Foundation Denton A. Cooley Fellow, Dr. Clauden Louis. The Denton A. Cooley Fellowship is part of the AATS Foundation's Honoring Our Mentors Program and is funded by generous donors, including several of Dr. Cooley's trainees. The selected fellow spends up to four weeks studying at the Texas Heart Institute (THI) and Baylor St. Luke's Medical Center (BSLMC), learning from its team of world-renowned physicians and researchers. The Denton A. Cooley Fellowship provides an educational experience for North American cardiothoracic surgeons in their final year of residency or who recently completed their residency. The AATS established the program to honor those cardiothoracic surgeons who have demonstrated long-standing leadership and dedication over the course of their careers. The 2022 Denton A. Cooley Fellow is Dr. Clauden Louis, MD, MS, MPH, a recent University of Rochester Integrated Cardiothoracic Surgery Residency graduate. He is also a graduate of Howard University Medical School and Johns Hopkins Bloomberg School of Public Health. He is continuing his training with an Endovascular Cardiac Surgery Fellowship at Brigham & Women's Hospital before returning to his native home of Florida to join a surgical practice there. THANK YOU FOR WATCHING! ----------------------STAY CONNECTED ------------------

Fred is the Co-Chair and Director of the Council for a Secure America stop by the podcast, and we have a discussion that is critical for the energy security of the United States. 00:00 - Intro00:03:14 -Real Clear Energy Policy (Article)06:19 - An attribute that back again all to oil.10:17 -Talks about Sanctions12:14 - New Pipelines, Leviathan field is critical to replace the Russian gas16:49 - New York is banning natural gas stoves and Talks About Pipelines20:25 - Talks about China-Emission- Natural Gas-Building a coal plant23:46 - Bitcoin miners up25:50 - America's Energy Issue31:00 - OutroAboutOver the course of his distinguished 45-year career, Mr. Zeidman has been involved in numerous high-profile workouts, restructurings and reorganizations. He was former CEO, President and Chairman of Seitel, Inc., a Houston-based provider where he was instrumental in the successful turnaround of the Company. He most recently served as Chief Restructuring Officer of Transmeridian Exploration, Inc. and Bankruptcy Trustee AremisSoft Corp. He held the post of Chairman of the Board and CEO of Unibar Corporation, the largest domestic independent drilling fluids company, until its sale to Anchor Drilling Fluids.Mr. Zeidman is also Chairman Emeritus of Gordian Group, the United States Holocaust Memorial Council, Chairman Emeritus of the University of Texas Health Science System Houston, interim Chief Financial Officer of the Texas Heart Institute and is Vice Chancellor of the Houston Community College System. He further serves on the Board of Directors and Executive Committee of the University of Saint Thomas and is National Campaign Chairman of Development Corp of Israel (Israel Bonds).

Jake Longly, ex-pro baseball player turned restauranteur, is back where he belongs: relaxing on the beach in front of his restaurant in Gulf Shores, Alabama. His peace is interrupted, however, when he receives a call from his private investigator father—April Wilkerson has gone missing from Lindemann Farms, the rustic, yet posh, resort built by self-help and financial guru Jonathon Lindemann. Lindemann, founder of The Lindemann Method (TLM), recruits wealthy people to join his program, charging a hefty entry fee but in return promising huge financial gains and self-enlightenment. Jake's celebrity status makes him the best person for the case. When Jake and his girlfriend, Nicole, go on an undercover visit to Lindemann Farms, some suspicious activity makes them wonder about the legitimacy of TLM. Soon, a private conversation with one of the girls hired to work at the resort reveals their unorthodox, and immoral, recruitment methods. As the layers peel away, darker edges appear. Does Jonathon truly make money for his investors, or is he a scam artist? Is April merely the latest in a series of missing young women? Jake and Nicole need to find her, and soon, before TLM catches wind of their true reasons for visiting the farm. DP Lyle, MD is the Amazon #1 Bestselling; Macavity and Benjamin Franklin Silver Award winning; and Edgar (2), Shamus, Agatha, Anthony, Scribe, USA Today Best Book Award (2), and Foreward INDIES Book of the Year nominated author of 23 books, both non-fiction and fiction, including the SAMANTHA CODY, DUB WALKER, JAKE LONGLY, and CAIN/HARPER thriller series, and the ROYAL PAINS media tie-in novels. His essay on Jules Verne's THE MYSTERIOUS ISLAND appears in THRILLERS: 100 MUST READS and his short story “Even Steven” in ITW's anthology THRILLER 3: LOVE IS MURDER. He served as Editor for the Southern California Writers Association's short story anthology, IT'S ALL IN THE STORY as well as contributed the story “Splash.” His short stories “Bottom Line” appears in the Sherlock Holmes-inspired anthology FOR THE SAKE OF THE GAME and “Tonic” can be found in the anthology NOTHING GOOD HAPPENS AFTER MIDNIGHT. ​ He has worked with many novelists and with the writers of popular television shows such as Law & Order, CSI: Miami, Diagnosis Murder, Monk, Judging Amy, Peacemakers, Cold Case, House, Medium, Women's Murder Club, 1-800-Missing, The Glades, and Pretty Little Liars. ​ He has taught fiction writing at numerous writing conferences as well as classes at The Learning Tree University and the UCLA Extension Writing Program. ​ He was born and raised in Huntsville, Alabama where his childhood interests revolved around football, baseball, and building rockets in his backyard. The latter pursuit was common in Huntsville during the 1950s and '60s due to the nearby NASA/Marshall Space Flight Center. ​ After leaving Huntsville, he attended college, medical school, and served an internship at the University of Alabama; followed by a residency in Internal Medicine at the University of Texas at Houston; then a Fellowship in Cardiology at The Texas Heart Institute, also in Houston. For the past 40 years, he has practiced Cardiology in Orange County, California. ​ ​

Jake Longly, ex-pro baseball player turned restauranteur, is back where he belongs: relaxing on the beach in front of his restaurant in Gulf Shores, Alabama. His peace is interrupted, however, when he receives a call from his private investigator father—April Wilkerson has gone missing from Lindemann Farms, the rustic, yet posh, resort built by self-help and financial guru Jonathon Lindemann. Lindemann, founder of The Lindemann Method (TLM), recruits wealthy people to join his program, charging a hefty entry fee but in return promising huge financial gains and self-enlightenment. Jake's celebrity status makes him the best person for the case. When Jake and his girlfriend, Nicole, go on an undercover visit to Lindemann Farms, some suspicious activity makes them wonder about the legitimacy of TLM. Soon, a private conversation with one of the girls hired to work at the resort reveals their unorthodox, and immoral, recruitment methods. As the layers peel away, darker edges appear. Does Jonathon truly make money for his investors, or is he a scam artist? Is April merely the latest in a series of missing young women? Jake and Nicole need to find her, and soon, before TLM catches wind of their true reasons for visiting the farm. DP Lyle, MD is the Amazon #1 Bestselling; Macavity and Benjamin Franklin Silver Award winning; and Edgar (2), Shamus, Agatha, Anthony, Scribe, USA Today Best Book Award (2), and Foreward INDIES Book of the Year nominated author of 23 books, both non-fiction and fiction, including the SAMANTHA CODY, DUB WALKER, JAKE LONGLY, and CAIN/HARPER thriller series, and the ROYAL PAINS media tie-in novels. His essay on Jules Verne's THE MYSTERIOUS ISLAND appears in THRILLERS: 100 MUST READS and his short story “Even Steven” in ITW's anthology THRILLER 3: LOVE IS MURDER. He served as Editor for the Southern California Writers Association's short story anthology, IT'S ALL IN THE STORY as well as contributed the story “Splash.” His short stories “Bottom Line” appears in the Sherlock Holmes-inspired anthology FOR THE SAKE OF THE GAME and “Tonic” can be found in the anthology NOTHING GOOD HAPPENS AFTER MIDNIGHT. ​ He has worked with many novelists and with the writers of popular television shows such as Law & Order, CSI: Miami, Diagnosis Murder, Monk, Judging Amy, Peacemakers, Cold Case, House, Medium, Women's Murder Club, 1-800-Missing, The Glades, and Pretty Little Liars. ​ He has taught fiction writing at numerous writing conferences as well as classes at The Learning Tree University and the UCLA Extension Writing Program. ​ He was born and raised in Huntsville, Alabama where his childhood interests revolved around football, baseball, and building rockets in his backyard. The latter pursuit was common in Huntsville during the 1950s and '60s due to the nearby NASA/Marshall Space Flight Center. ​ After leaving Huntsville, he attended college, medical school, and served an internship at the University of Alabama; followed by a residency in Internal Medicine at the University of Texas at Houston; then a Fellowship in Cardiology at The Texas Heart Institute, also in Houston. For the past 40 years, he has practiced Cardiology in Orange County, California. ​ ​

Welcome to "On Pump," a podcast that highlights the amazing work of cardiovascular perfusionists around the world. In this episode, we are honored to have Robert Groom as our guest. Robert Groom is a highly respected and renowned cardiovascular perfusionist who has made significant contributions to the field. He currently works at Tenwek Hospital in Bomet, Kenya, where he is developing a perfusion program and helping to build the largest cardiac center in Sub-Saharan Africa. Bob, as he is affectionately known, has had a long and distinguished career in the United States before moving to Kenya. He received his Bachelor of Science in Biology from Geneva College and completed his perfusion education at the Texas Heart Institute. He also holds a Master's of Science in Evaluative Clinical Sciences from Dartmouth Medical School. Bob has held various positions in the field of perfusion, including serving as the Interim Vice President and Director of Cardiovascular Perfusion at Maine Medical Center. He is decorated recipient of the John H. Gibbon Jr. Award, which recognizes individuals who have made significant contributions to the cardiopulmonary discipline. In this episode, Bob shares his inspiring story and testimony, and how his journey lead him to working in Kenya. He talks about his experiences in starting a perfusion program at Tenwek Hospital, and the challenges and rewards of working in a developing country. Bob is well-published in medical journals and book chapters, and he emphasizes the importance of being a member of your professional society. We encourage listeners to donate to the development of his cause in Kenya through the World Gospel Mission website at www.wgm.org, specifically at www.wgm.org/missionary/groom and scrolling down to related projects. Thank you for listening to this episode of "On Pump" featuring Robert Groom, a true icon in the field of perfusion. We hope you find his story as inspiring as we do. Bob's incredible journey will be continued in episode 5 to follow.

Dr. Joseph Rogers, CEO and President of Texas Heart Institute, joined Dr. Galati recently on his weekly radio program, sharing his thoughts on heart disease. Dr. Rogers spoke about risk factors for heart, disease, and lifestyle changes that can be made to reduce the progression of heart disease, as well as its associated mortality.Information on Dr. Rogers is available here, along with information about the Texas Heart Institute.Information from the American Heart AssociationHealthy EatingHeart Attack and Stroke SymptomsYour Cholesterol Hosted on Acast. See acast.com/privacy for more information.

Dr. Doris A. Taylor, Ph.D. is Chief Executive Officer of Organamet Bio Inc. (https://organametbio.com/) an early phase start-up committed to saving lives and reducing the cost of healthcare for those with heart disease. Organamet has a goal is to make personalized bio-engineered human hearts, available to all who need them, within 5 years, increasing availability and access to hearts, decreasing or eliminating need for immunosuppression, reducing total lifetime transplant costs, and improving quality of life. Dr. Taylor was previously the Director, Regenerative Medicine Research and Director, Center for Cell and Organ Biotechnology, at the Texas Heart Institute in Houston, Texas, where she worked on the integration of regenerative medicine and tissue engineering. Dr. Taylor has a Ph.D. in Pharmacology from UT Southwestern Medical Center, Dallas, Texas. She did her post-doctoral studies at Albert Einstein College of Medicine in the Bronx, New York, where she first worked with tissue engineering, growing heart muscle cells in the laboratory. Dr. Taylor was on the faculty of Duke University from 1991 to 2007, and then moved to University of Minnesota, where in 2008 her team published a landmark paper in Nature Medicine where they created new beating rat hearts using a combination of tissue engineering processes, first stripping the dead dying cells away from an existing heart (in a process called "de-cellularization") leaving behind the hearts extracellular matrix and then re-seeding the matrix by injecting new young rat stem cells. Dr. Taylor is also Co-Founder and original Board member of Miromatrix Medical Inc. Dr. Taylor's work has been published in Nature Medicine, Circulation Research, The Journal of Molecular Biology, The Journal of Biochemistry, Journal of the American College of Cardiology (JACC), Journal of the American Medical Association (JAMA), and other top-tier scientific journals. She holds a numDev InterruptedWhat the smartest minds in engineering are thinking about, working on and investing in.Listen on: Apple Podcasts Spotify Healthy Lifestyle Solutions with Maya AcostaAre you ready to upgrade your health to a new level and do so by learning from experts...Listen on: Apple Podcasts Spotify Stop Drinking and Start Living Podcast With Expert Holistic Alcohol Coach, Mary WagstaffPractical Tools & Strategies To Get Alcohol Out Of Your Way & Enhance Your LifeListen on: Apple Podcasts Spotify Tiny MattersA science podcast about the little things that make the big things—good and bad—possible.Listen on: Apple Podcasts Spotify

Lelio Souza é mineiro e formado em Engenharia Mecânica pela Universidade Federal de Minas Gerais. Trabalhou como consultor de tecnologia e gestão na Accenture e depois teve a oportunidade de migrar para a TOTVS, onde atuou na área de Data Center e finalizou seu trabalho como Head de Operação Comercial no Brasil. Hoje, atua como Vice-Presidente da AFYA. Bruno Lagoeiro é carioca e formado em Medicina pela Universidade Federal Fluminense e tem experiência como Research Observer no Texas Heart Institute e diversas participações em trabalhos acadêmicos. Durante a graduação, desenvolveu aplicativos voltados para a área de atuação junto com os colegas de faculdade. Cofundou a PEBMED, empresa focada no desenvolvimento de soluções de apoio à tomada de decisão clínica. Atualmente, é Diretor de Produtos Digitais da AFYA.

This past week on Your Health First, Dr. Briana Costello with the Texas Heart Institute, shared her experience on metabolic syndrome and its role in heart disease and fatty liver. Metabolic syndrome generally consists of: obesity (specifically belly fat), pre or type 2 diabetes, high blood pressure, and increased levels of cholesterol. Fatty liver is seen in the vast majority of such cases of metabolic syndrome. Unfortunately, those with metabolic syndrome have an increased chance of developing serious heart complication - such as heart attack, stroke, and premature death.For more information about Dr. Costello and the Texas Heart Institute, visit these links.#metabolicsyndrome#texasheartinstitute#fattyliver#liverspecialistsoftexas See acast.com/privacy for privacy and opt-out information.

How can we utilize the regenerative stem cells already found in the human adult body to combat the effects of heart failure? Dr. Alain Bouchard discusses this cutting edge realm of medicine with Dr. Emerson Perin, director of the Center for Clinical Research at the Texas Heart Institute.Learn more about stem cells for the treatment of heart failure here.About the HostDr. Alain Bouchard is a clinical cardiologist at Cardiology Specialists of Birmingham, AL. He is a native of Quebec, Canada and trained in Internal Medicine at McGill University in Montreal. He continued as a Research Fellow at the Montreal Heart Institute. He did a clinical cardiology fellowship at the University of California in San Francisco. He joined the faculty at the University of Alabama Birmingham from 1986 to 1990. He worked at CardiologyPC and Baptist Medical Center at Princeton from 1990-2019. He is now part of the Cardiology Specialists of Birmingham at St. Vincent's Health System, Ascension.Medical DisclaimerThe contents of the MyHeart.net podcast, including as textual content, graphical content, images, and any other content contained in the Podcast (“Content”) are purely for informational purposes. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or heard on the Podcast!If you think you may have a medical emergency, call your doctor or 911 immediately. MyHeart.net does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Podcast. Reliance on any information provided by MyHeart.net, MyHeart.net employees, others appearing on the Podcast at the invitation of MyHeart.net, or other visitors to the Podcast is solely at your own risk.The Podcast and the Content are provided on an “as is” basis.

A revealing chat with one of the brightest minds in medical science. The Texas Heart Institute's renowned surgeon and medical device inventor, Dr. Billy Cohn, explains how he and his colleague installed the world's first artificial heart in a living patient 11 years ago. Dr. Cohn offers an amazing insight into how a small team of scientists may be on the cusp of a game-changing breakthrough in cardiology.  See omnystudio.com/listener for privacy information.

Fred Zeidman, a prominent Houston based business and civic leader, joins America's Roundtable co-hosts Natasha Srdoc and Joel Anand Samy in addressing the importance of America securing its energy independence amid the adverse economic impact on American families and businesses, the state of US-Israel relations, the challenges in the Middle East and the accomplishments of the historic Abraham Accords and how it impacts of the United States' policy in the region and beyond. The conversation will also bring to the forefront the rise of anti-Semitism and the Boycott, Divestment and Sanctions movement (BDS) targeting Israel. Fred Zeidman presents a principled approach on how America's stakeholders and leaders can best address this growing concern. Fred Zeidman is the Co-Chair and Director of Council for a Secure America. He served as Chairman of the United States Holocaust Memorial Council and was appointed by President George W. Bush in March 2002, serving in that position from 2002-2010. Mr. Zeidman also is Chairman Emeritus of the University of Texas Health Science System Houston, interim Chief Financial Officer of the Texas Heart Institute and serves on the Board of the Institute for Rehabilitation and Research (TIRR). He further serves on the Board of Directors and Executive Committee of the University of Saint Thomas and Houston Community College. Mr. Zeidman currently serves as Chairman of the Board of Petroflow Energy, and as a Director of Petro River Oil, Hyperdynamics Corp., Straight Path Communications, Inc. and Prosperity Bank in Houston. He was formerly Chairman of The Gordian Group, Chairman of the Board of SulphCo Inc., Chief Restructuring Officer of Transmeridian Exploration, Inc. and Bankruptcy Trustee of AremisSoft Corp. He has previously served as Chairman of the Board of Seitel Inc. and Unibar, Inc. Fred Zeidman serves on the board of the Republican Jewish Coalition and the Development Corporation of Israel (Israel Bonds), and served on the Board of the National World War II Museum. https://ileaderssummit.org/services/americas-roundtable-radio/ https://ileaderssummit.org/ | https://jerusalemleaderssummit.com/ America's Roundtable on Apple Podcasts: https://podcasts.apple.com/us/podcast/americas-roundtable/id1518878472 Twitter: @ileaderssummit @NatashaSrdoc @JoelAnandUSA America's Roundtable is co-hosted by Natasha Srdoc and Joel Anand Samy, co-founders of International Leaders Summit and the Jerusalem Leaders Summit. America's Roundtable from Washington D.C. informs, educates, empowers and challenges the listening audience about the importance to restore, strengthen, and protect our freedoms, the rule of law, and free markets. America's Roundtable advances the ideas of freedom, the significance of freedom of speech, limited government, and the application of free market principles to solve problems. America's Roundtable presents in-depth analysis of current events and public policy issues while applying America's founding principles. America's Roundtable radio program - a strategic initiative of International Leaders Summit, focuses on America's economy, healthcare reform, rule of law, security and trade, and its strategic partnership with rule of law nations around the world. The radio program features high-ranking US administration officials, cabinet members, members of Congress, state government officials, distinguished diplomats, business and media leaders and influential thinkers from around the world. America's Roundtable is aired by Lanser Broadcasting Corporation on 96.5 FM and 98.9 FM, covering Michigan's major market and the upper Midwest, SuperTalk Mississippi Media's 12 radio stations and 50 affiliates reaching every county in Mississippi and also heard in parts of the neighboring states, including Alabama, Arkansas, Louisiana and Tennessee, and through podcast on Apple Podcasts and other key online platforms.

Feeling like this pandemic & climate change doesn't end? Feel like an impending apocalypse is upon us? How we do weed through the next catastrophic event? Join me as I interview Dr. Othman who is an anesthesiology resident as we dive into the profession and how it is a perfect analogy to our current times. WATCH THE YOUTUBE VERSION HERE: https://youtu.be/DtE4A7PHHw0  Nabil Othman completed medical school at Wayne State School of Medicine in Detroit, MI followed by an anesthesiology residency at Cedars Sinai Hospital in Los Angeles, CA. In his 4th year of residency, he wrote a book called "Vigilance: An Anesthesiologist's Notes on Thriving in Uncertainty." The book describes anesthesiology in terms of complex systems, synergistic interactions, and rare catastrophic events called Black Swans. Currently, he is a critical care fellow at the Texas Heart Institute in Houston, TX. In his free time, he enjoys CrossFit, hiking, and writing. https://airwaybagelcoffee.com/ ***This episode was previously LIVE, so giveaways, comments, and questions cannot be entertained at this time. Find the other YouTube episodes here: https://bit.ly/TheChefDocYT Follow us every Wednesday for a new LIVE Q&A Episode at 5 pm PST. --- Listen to other Thrive Bites Episodes here: https://www.thethr5formula.co/podcast Join our NEW THR5 FB Community here: https://www.facebook.com/groups/theth... --- *This episode is sponsored by The THR5 Formula™ Virtual Summit Experience at https://www.thethr5formula.co/ *This episode is sponsored by Listenable.io. Special offer for Thrive Bites listeners, using the coupon code {colinzhu} at listenable.io, and you'll get 30% off a year of Listenable. *This episode is sponsored by Betterhelp. Special offer for Thrive Bites listeners, get 10% off your first month at http://betterhelp.com/thechefdoc _________________ *Interview views are opinions of the individual. This podcast is not a source of medical or dental advice* Copyright © 2021 by TheChefDoc, LLC All text, graphics, audio files, Java applets and scripts, downloadable software, and other works on this website are the copyrighted works of TheChefDoc, LLC. All Rights Reserved. Any unauthorized redistribution or reproduction of any copyrighted materials on this website is strictly prohibited.

Dr. Joe Galati wants you to understand the health issues at hand. He talks about chronic disease and the mind body connection. Dr. Joseph Rogers of the Texas Heart Institute in Houston joins the show to share some thoughts.

This past week on our weekly radio show, Your Health First, our special guest was Dr. Joseph Rogers, the new President and CEO of the world famous Texas Heart Institute located in the Texas Medical Center. During the interview, we asked Dr. Rogers a number of questions about heart disease and what the average consumer needs to know.Topics we talked about include understanding risk factors for heart disease, understanding the new American Heart Association guidelines for the control of high blood pressure, the role of statins and their safety, as well as being familiar with symptoms you may have that are associated with serious heart problems. He also discussed the need to know your cholesterol, even at an early age, say 20 years old. The better you understand personal risk factors, the sooner lifestyle changes can be adjusted, medical interventions can be made, and your overall health, wellness, and survival can benefit.#americanheart #hearthealth #highbloodpressure #cholesterol #texasheartinstitute #heartattack #talkradio #iheartradioWebsites to remember:Dr. Galati's newsletter sign-upMedical Practice: Liver Specialists of TexasDr. Galati's Book Site: Eating Yourself SickFacebook: Dr. Joe GalatiDr. Galati's YouTube ChannelPlease send feedback and suggestion. You can message me here. See acast.com/privacy for privacy and opt-out information.

Als vor 52 Jahren die Astronauten der Apollo 11 den Mond betraten, saß auch Johannes Albes als Neunjähriger vor dem Fernseher. In den Pausen der Live-Übertragung wurden andere spektakuläre Bilder gezeigt: von einer Herzklappenoperation im "Texas Heart Institute". Das hat Johannes Albes im niedersächsischen Vechta so fasziniert, dass er nicht Astronaut, sondern Herzchirurg werden wollte.

COVID hospitalizations are falling, immunity is rising, and a revolutionary vaccine is free and accessible to every American. So why does the fear, the call for lockdowns, and the “wear a mask at all times” doctrine – whether you’re vaccinated or not – still persist among the left and mainstream media? Dr. Reynolds Delgado returns to examine the collectivist ideology and slippery slope of social engineering which is driving much of the pandemic response, and the untold damage it’s causing our society. We also discuss how viruses evolve, the new tech behind vaccine production, and protecting the ecosystem of medical innovation which enables that tech to thrive in America. Dr. Reynolds Delgado, III, is a cardiologist specializing in heart failure and heart transplantation at Baylor St. Luke's Medical Center/Texas Heart Institute. Dr. Delgado has been a Basic Science Researcher in Heart Failure at the Texas Heart Institute, Baylor College of Medicine, and The University of Texas Houston Medical School since 1997, and has held the position of Medical Director of Mechanical Support Devices in Heart Failure at the Texas Heart Institute since 2003. His academic appointments include clinical assistant professor of medicine at Baylor College of Medicine and UT Health Science Center, Houston. He participates on numerous advisory boards, Including Thoratec Corporation, Medtronic Corporation, and Boston Scientific Corporation, and has been on the Medical Education Committee at Texas Heart Institute since 2004. He is also a long-standing research collaborator with NASA Johnson Space Center Human Space Flight Physiology Laboratory.

The Texas Heart Institute was looking for a way to support in-house innovation as well as connecting the organization to the latest and greatest health care technology — and so they created a new job. THI's new manager of innovation partnerships, Allison Post, joins the show today to share what THI is focused on and how it's now time for Houston's health care leaders to join forces to advance life science tech.

Dr. Reynolds Delgado, III, is a cardiologist specializing in heart failure and heart transplantation at Baylor St. Luke's Medical Center/Texas Heart Institute. He joins us for a conversation about what doctors like himself are learning as they treat patients on the front lines of the COVID-19 pandemic. Dr. Delgado has been a Basic Science Researcher in Heart Failure at the Texas Heart Institute, Baylor College of Medicine, and The University of Texas Houston Medical School since 1997, and has held the position of Medical Director of Mechanical Support Devices in Heart Failure at the Texas Heart Institute since 2003. His academic appointments include clinical assistant professor of medicine at Baylor College of Medicine and UT Health Science Center, Houston. He participates on numerous advisory boards, Including Thoratec Corporation, Medtronic Corporation, and Boston Scientific Corporation, and has been on the Medical Education Committee at Texas Heart Institute since 2004. He is also a long-standing research collaborator with NASA Johnson Space Center Human Space Flight Physiology Laboratory.

This week’s episode is special: we have the former and current Editors-in-Chief of Circulation on Circulation on the Run. Join Dr Amit Khera, Digital Strategies Editor of Circulation, as he speaks with Dr James T. Willerson, Editor-in-Chief from 1993 to 2004; Dr Joseph Loscalzo, Editor-in-Chief from 2004 to 2016; and Dr Joseph A. Hill, the current Editor-in-Chief. They will discuss the history of Circulation and how it continues to evolve. TRANSCRIPT Dr Amit Khera: Hi, this is Amit Khera. I'm digital strategies editor for Circulation from UT Southwestern Medical Center in Dallas. Today we have a very special Circulation on the Run. We have three Editors-in-Chief from Circulation. First, we have Dr James Willerson, who was the Editor-in-Chief from 1993 to 2004. He's a President Emeritus at the Texas Heart Institute. We also have Dr Joseph Loscalzo, who was Editor-in-Chief from 2004 to 2016, the Chairman of Department of Medicine from Brigham and Women's Hospital. And finally, Dr Joseph Hill, the current Editor-in-Chief, the Chief of Cardiology at UT Southwestern Medical Center. Welcome, gentlemen. Dr Joseph Hill: Thank you. Dr James Willerson: Thank you. Dr Joseph Loscalzo: Thank you. Dr Amit Khera: Dr Willerson, I must say, looking over the tenure prior to Dr Loscalzo, you had one of the longest tenures ever as Editor-in-Chief of Circulation, and certainly a lot happened in the practice of cardiology during that period. It was a really formative period in cardiology. As you think back, what were some of the most important topics that you covered during that time as Editor-in-Chief, thinking about the evolution of cardiovascular care and science at that time? Dr James Willerson: You have to remember, there have been many editors at Circulation. We all build on the shoulders of others, certainly I did. I really wanted Circulation to be the premier cardiovascular journal in the world. I wanted it to be much like the New England Journal of Medicine, but the New England Journal of Medicine Circulation of Cardiology. I wanted to publish it every week. We got permission to do that. That wasn't easy, but we were fortunate. I've been accused of wanting to publish it every day. There's actually some truth to that. I didn't make that. I didn't try very hard. I wanted to be able to present the information, important information, to everybody who cared about cardiovascular medicine: physicians, scientists, students, nurses, those who cared for people, and I wanted to do it frequently. I wanted to publish it quickly. So, we had some success with that. There are many other things that are well-known to the other editors, all of whom have built before me and after me, and I'm very proud of them. Dr Amit Khera: Well, thanks for that. And certainly, as you pointed out, this has been an evolution where you took the gauntlet, if you will, from the people before you, and then built on that and had many advances. I guess after you, Dr Loscalzo, you I think did have the longest tenure if I saw of any of the editors and similarly, a lot of evolutions in cardiovascular care and a lot in science, particularly during your time. Tell us a little bit about any particular papers or topics that you focused on, or that really were revolutionary in the cardiovascular space during your tenure. Dr Joseph Loscalzo: I'll pick up where Jim left off and just make the case that as you're suggesting, I mean, there's sort of been a natural transition of the kind of science that Circulation has been publishing over the tenure of the three editors here today. Before Dr Willerson, it was largely physiology and excellent clinical science. Jim really expanded the scope of what Circulation published to begin to put in press in its pages, fairly basic and translational science as well. I picked up from what he'd laid the groundwork for to expand the scope of that science. And as you know, expand it to the point that we had to develop daughter journals that would pick up the mantle in each of these increasingly subspecialized areas. So, it's hard to think about those papers that I found have the greatest impact because every field had several of them in my several years as editor. As you know, the subspecialty journals that we established, which remain active to the current time, are also broad in their scope from outcomes based research to genomics and proteomics insistence, cardiovascular medicine, to everything in between, imaging, intervention, heart failure, and electrophysiology to arrhythmias. Each of these was led, and continues to be led, by outstanding leaders in their subspecialty fields. I think the beauty of Circulation in contrast to even fine journals like the New England Journal of Medicine, is that Circulation has been able to put on its pages those studies that really do span quite a spectrum. We don't shy away from very basic studies. That actually began with Jim, I must say, because that wasn't the case previously. And of course, we move right through to epidemiology and outcomes based research. And the impacts have been broad in each of those fields, as witnessed by the excitement and uptake of the journal, measured however you wish, by impact factor, or citations, or the frequency with which it's referred to in the lay press. So, I think that tradition certainly continues under the current editor with papers of extraordinary impact. Dr Amit Khera: Thanks for that. I think your point about the evolution of science over time from Dr Willerson and certainly during your tenure and beyond to the breadth of Circulation currently. You also touched on the subspecialty journals. That happened in your watch and that was quite a marked change in cardiovascular medicine to have that explosion of new journals, if you will. What do you think the impact of those subspecialty journals has been for the cardiovascular field? Dr Joseph Loscalzo: We struggled with the idea about whether or not we should pursue that kind of fragmentation. What really pushed us was the fact that the acceptance rate remains quite low, in those days, probably eight or so percent range at its nadir. So, we were rejecting a lot of really excellent papers which wound up in competitor journal pages, that we would like to have accepted and been given the scrutiny of the careful reviews and editorials that accompany papers accepted by Circulation. We felt the best way to do that under the circumstances was to create these daughter journals. They succeeded, in many respects, beyond our wildest imagination. The numbers of papers that were published in the family increased, I think in the first two or three years, by at least 2-to 3000. So, that really speaks to the fact that we kept the best papers in the family. We gave them the right kind of audience. Some of these would have been too technical or too highly specialized to have been published in Circulation proper, but certainly of the highest quality and of significant relevance to the subspecialist. So, we think that it was a successful experiment. Now it's sort of become tradition. I think that the question that will always come up, of course, is can we fragment things more? I would say one of the best reasons to make the case that this was a successful experiment is that if imitation's the sincerest form of flattery, the New England Journal is now going to start three subspecialty journals. In fact, in my role now as an editor of the New England Journal, editor-at-large, they asked my input in how to design those daughter journals and what to expect from them. Dr Amit Khera: Well, I think that's a great point. It certainly has been a resounding success and as you pointed out, imitation is the best form of flattery. I'm going to pivot now to Joe Hill. Dr Hill, you have certainly been the beneficiary of all the great work that these two editors have done in the past. You've inherited a very successful journal and also have crafted your own vision for where you want Circulation to go in your mark. Tell us a little bit about some of the new initiatives you've tried to implement, leveraging on these past successes. Dr Joseph Hill: Thank you, Amit, it's an honor and a privilege to be in this conversation, frankly. I mean, Dr Willerson made this a weekly journal. That was back in the day when FedExes were flying around. Everything was paper. That kind of volume with that technology is impressive. And Dr Loscalzo, who has been a friend and mentor for many, many years, spearheaded the subspecialty journals, as we just heard, and took the journal to yet new heights. Each of you has been a pioneer and we've been fortunate to put together a team that I think has moved in exciting directions. We've leveraged technology now, such that we have our video conference meetings. We meet in a video conference with editors from 17 different countries. We have a third of our editors in Dallas, where I live, a third in the US outside of Dallas, and another third in 16 other countries. It turns out we alternate the time of that meeting each week because there's no single hour of the day that works around the globe, so we move it around to capture Asia or to capture California in alternating weeks. That has been a thrill and, honestly, I believe a robust success. We have leaders on the ground in all these different countries. We have a highly diverse team across the different subspecialty domains of cardiology, across different geographic regions, across race and sex and gender lines. It is an amazing team. And Amit, who leads our robust digital efforts, including this podcast and our efforts on social media, again, the opportunity now in the 21st century to take these initiatives forward has been a real privilege. Dr Amit Khera: It's ironic that Circulation was doing Zoom before everybody else was in the modern era. I'm going to pivot back to Dr Willerson. As Dr Hill just mentioned during your tenure how the volume of papers was handled, FedEx and sort of the nature of the journal publishing process. And now in the modern era, we have so much different information. We have a huge volume of journals. We have online, we have Twitter, we have podcasts. We have people that are consuming information in so many different ways. Tell us from your perspective, what's the role of the scientific journal currently and how has it changed at all in the last few decades? Dr James Willerson: It's always going to continue to evolve. It's about as good as it can be right now with Dr Loscalzo and Dr Hill's leadership, and I'm really proud of them. There'll be more. We can't even imagine what it will be in two or three years. Of course, it'll be better and better, faster, almost momentary. Thank you, Dr Hill. Dr Amit Khera: Thank you for that. I think we all look forward to seeing how this evolves more rapid information, rapid turnaround. I'm certain that will change. Dr Hill, you had a comment on that? Dr Joseph Hill: We live in an era now where peer review is under attack in many ways and pre-print journals, blogs and so forth. And one of the things that I've really seen, and we've all seen, is how the peer review process, and we're all authors, right, we live on the other end of that stick, but it really is important. It makes a big difference. And people who are anxious to accelerate that process, I totally get it. We work very hard to do that. At the same time we, following the traditions here, have an intentionally redundant review process where every paper is evaluated by multiple editors and multiple peer reviewers. On a number of occasions, we've avoided a pothole, or we've improved a paper many, many times. And that is something that has really been impressed on me that I think people who aren't on this side of the editorial fence might not appreciate as much. Dr Amit Khera: I think that's an important point about sort of the rigor about the way that articles come out in Circulation. And Dr Loscalzo, maybe as an extension of the last question, what do you see as some of the challenges going forward or opportunities for Circulation? You think about where it's been, but what are some of the things that you look forward to for Circulation in the future and what are some of the things you're concerned about? Dr Joseph Loscalzo: Well, I too am concerned about this issue of peer review being under attack, and I'm particularly concerned about it for papers that have direct clinical impact. A good example of that concern, of course, are papers published, or at least publicly released, on non-peer reviewed websites like the archive sites because of their importance in the COVID epidemic, potentially. We all know of cases of drugs, at least in test tubes, with cultured cells and viruses appear to be effective that have adverse clinical consequences. So that, and more than in any other sphere of science, ensuring that proper peer review from as many perspectives as possible is always a part of the process is absolutely critical for clinical medicine. And to me, the threat that this need for acceleration and rapid peer review poses and the sort of socialization of the transmission of scientific information that we're all interested in doing really has to have the brakes put on it a bit for the clinical science that the journal represents for this very important reason. Not to say we want to slow things down, we want to make sure that the best possible reviews are performed before we release it to the public. I know that, as Joe was pointing out, one of the most exciting parts of the role of when I led the journal was the weekly meeting. We had a face-to-face meeting because all of our associate editors, save one, was actually physically proximate and they could travel to our conference room. But it's a wonderful exercise to have people of very different perspectives, from basic scientists, to clinical electrophysiologists, to outcomes researchers, make comments on papers that were completely outside their sphere. The argument, of course, is if one can write and transmit a thought with the clear intent in a way that's rigorous and logical, that any reasonably bright person with reasonable scientific background should be able to understand it. And often these folks with very different scientific backgrounds have perspectives that very clearly improved the paper when they were acted upon. That's a process that doesn't exist in many other journals, I have to say. And I would encourage Joe, which I know, well, he's doing this because he enjoys it and he recognizes its importance, and Joe's successors continue to do that as well because that will ensure the value of the journal through all of the challenges that it is going to have to face in the next decade or two. Dr Amit Khera: I think that was a great point. We're certainly seeing candy bowl examples of the importance of this rigorous process of the editors looking through it carefully and, as you both mentioned, peer review. Joe Hill, I'm going to let you maybe have the last word. I know how hard the three of you have historically worked on your craft for the journal, how much effort you've put in, but I also know it's quite a rewarding job. What would you see as the best part of being Editor-in-Chief of Circulation? Dr Joseph Hill: Oh my, I'm learning something every day. I've been on about a steep a learning curve as when I was an intern at Dr Loscalzo's hospital long ago. Under Dr Willerson's term, I imagine many, many studies came in on acute coronary syndromes and thrombolytic therapy, primary PCI, antiarrhythmic drugs. We haven't seen an antiarrhythmic drug paper except for a recent review we did, but for quite a long time. It's artificial intelligence, it's big data, it's the UK Biobank, it's Omix, it's incredibly sophisticated genetics and genomics and basic science with genetic manipulations, IPS cells. It's a very different world now than it was 10 years ago, 20 years ago and it certainly will be again, 10 and 20 years down the road. We are now approaching, I will say, 600 COVID related papers, and they're still coming in at a record pace. The world has changed. As I said before, this is the 70th anniversary of this storied journal. And it is truly my honor to be able to stand on the shoulders of Doctors Loscalzo and Willerson. Dr Amit Khera: Thank you. I think that's a great way to end this podcast and congratulations on the 70th anniversary. It truly has been a privilege to chat with the three of you today. I want to thank you not only for what you've done for Circulation, but for the field of cardiovascular medicine. This is Amit Khera, digital strategies editor for Circulation. Next week we're back to our usual podcast with Carolyn Lam and Greg Hundley. Take care. Dr Greg Hundley: This program is copyright the American Heart Association, 2020.  

Our special edition of Houston Matters weekdays at 3 p.m. addresses your questions and concerns about coronavirus as a public service to our listeners. For this special episode, host Ernie Manouse is joined by U.S. Congressman Dan Crenshaw (TX 2nd District), Dr. Reynolds Delgado with the Texas Heart Institute, and Dr. John Diamond with Rice University's Baker Institute. The panel discusses COVID-19's impact on the economy and the healthcare system, and also fields questions from... Read More

NOW TRENDING ON ICONICLIFE.COM ICONIC HAUS...NOW VIRTUAL ICONIC HAUS The Heart Center at Phoenix Children’s Hospital is the beneficiary of ICONIC HAUS 2020  proceeds, and I talked with him about ten days ago before the coronavirus news intensified this week. As Co-Director of The Heart Center, Dr. Franklin shared the latest initiatives and innovative research coming out of The Heart Center, and why our support matters. Following my interview with Dr. Franklin, dear friend and father Justin Lee, owner of Moving Team Six and ICONIC HAUS sponsor, shares his personal story of how PCH saved his daughter’s life, and why he always says “yes” to Phoenix Children’s Hospital. Dr. Wayne Franklin Dr. Wayne Franklin is a graduate of Williams College in Williamstown, Massachusetts, and UCLA School of Medicine.  He did his residency training in Internal Medicine and Pediatrics at Duke University, where he first was exposed to Adult Congenital Heart Disease (ACHD).  He then did two simultaneous fellowships in adult cardiology and pediatric cardiology at St. Luke’s/Texas Heart Institute and at Baylor College of Medicine (BCM)/Texas Children’s Hospital (TCH) in Houston. In 2004, he founded the Texas Adult Congenital Heart Program, where he has served as Director from 2004-2018.  In 2013, he was appointed Chief of Cardiology at the TCH Pavilion for Women, where he directed the clinical and administrative cardiovascular service lines. In September of 2017, he was selected as Head of the Department Adult Medicine at Texas Children's Hospital and Associate Vice Chair of Clinical Operations in the Department of Pediatrics.  He is also the recipient of two prestigious Fulbright and Jaworski Awards of BCM Faculty Excellence, one in Teaching and one in Educational Leadership.  He came to Phoenix in 2018 to join Phoenix Children’s Hospital as the Co-Director of the Heart Center, the Director of the ACHD Program, and Chair of the Department of Adult Medicine.  In addition, he is a Full Professor in three University of Arizona-College of Medicine-Phoenix Departments, including the Departments of Medicine, Child Health, and Obstetrics and Gynecology.   Since his arrival, Dr. Franklin has transformed the care of adults with congenital heart disease in the Valley, and he has put together a team of experts in the field.  Phoenix Children’s Hospital is now undergoing accreditation to become the first hospital in Arizona to be accredited to comprehensive care of patients with adult congenital heart disease From an academic perspective, he is involved with several research projects on adults with congenital heart disease, specifically in patients with single ventricle-Fontan physiology, neurocognitive outcomes, pulmonary hypertension, cardiac disease in pregnancy, and most recently, transition medicine.  Dr. Franklin has been appointed to several medical advisory boards in congenital heart disease, including the Adult Congenital Heart Association (ACHA), the Alliance for Adult Research in Congenital Cardiology (AARCC), and American College of Cardiology (ACC). Since 2018, he has been the Co-Director of the Heart Center at Phoenix Children’s Hospital.  He has been an invited lecturer across North America, Europe, South America and South Asia.  He has offices in Central Phoenix, Scottsdale, Gilbert and Glendale.  In his off-time, Dr. Franklin likes to spend time with his two children and his wife, Rachel McNeill, anchor at 12 News/NBC-Phoenix. He remains a full-time husband, a lifetime father and a part-time golfer.   LINKS/RESOURCES Follow ICONIC LIFE digital luxury lifestyle magazine Instagram @youriconiclife Facebook @youriconiclife Twitter @youriconiclife   Check out ICONIC LIFE at ICONICLIFE.COM for fresh content published daily.  We invite you to SUBSCRIBE!   Follow Renee Dee Instagram @reneeldee  Twitter @iconicreneedee LinkedIn @ Renee Layman Dee If you enjoyed today’s podcast, I’d be so appreciative if you’d take two minutes to subscribe, rate and review ICONIC HOUR. It makes a huge difference in our growth. Thank you so much for supporting me to do what I do!

The human heart is one of the most complicated organs in our body. The heart is, in a way, like a machine—the muscular organ pumping about 2,000 gallons of blood in an adult human every day. But can we construct a heart in the lab? Some scientists are turning to engineering to find ways to preserve that constant lub dub when a heart stops working. One team of researchers created a biohybrid heart, which combines a pig heart and mechanical parts. The team could control the beating motion of the heart to test pacemakers and other devices. Their findings were published in the journal Science Advances in January. Mechanical engineering student Clara Park, an author on that study, talks about what it takes to engineer a biohybrid heart and how this model could be used in the future to develop implantable hearts and understand heart failure. At the Texas Heart Institute, Doris Taylor is developing a regenerative method for heart construction. She pioneered the creation of “ghost hearts”—animals hearts that are stripped of their original cells and injected with stem cells to create a personalized heart. So far, Taylor has only developed the technique with animal hearts, but in the future these ghost hearts could be used as scaffolds to grow transplant hearts for patients. Taylor talks about how much we know about the heart and why it continues to fascinate us. Last month Microsoft announced it is opening an office to represent itself to the United Nations. But what’s a tech company have to do with the U.N.? Meet the “Net State.” In her book The Information Trade: How Big Tech Conquers Countries, Challenges Our Rights, and Transforms Our World, Alexis Wichowski writes about how big tech companies are becoming much more than technology providers, and what it means for world citizens when powerful government-like entities—the “Net States”—transcend physical borders and laws.

This woman completely blew me away when I met her at the friends of nursing luncheon. She is Dr. Stephanie Coulter of Texas Heart Institute’s Center for Women’s Heart and Vascular Health. I think of her as a Dr. version of Attorney Elle Woods in Legally Blonde, mostly because of the fabulous hair flip and endearing southern/ Louisiana accent. She is BRILLIANT, truly changing the landscape for women’s health and yet absolutely darling.

D. P. Lyle is the award-winning, best-selling author of both fiction and nonfiction books. Sunshine State is the third in his best-selling Jake Longly mystery series. Earlier books in the series were finalists for the Shamus Award, Foreword Book of the Year Award, and USA Best Book Award, and included on Suspense Magazine’s Best Books of 2016 list. He is world renowned for his forensic expertise—the author of MacCavity Award winning and Edgar Award nominated Forensics for Dummies, now in its second edition. As a forensics expert, he has worked with the writers of popular television shows such as Law & Order, CSI: Miami, Diagnosis Murder, Monk, Judging Amy, Peacemakers, Cold Case, House, Medium, Women’s Murder Club, 1-800-Missing, The Glades, and Pretty Little Liars. He is a frequent speaker and radio and TV guest as well a valued forensic consultant to crime novelists. He is also International Thriller Writer’s V.P. for Education and responsible for CraftFest, Master CraftFest, and ITW’s online Thriller School. Lyle has an undergraduate degree and a medical degree from the University of Alabama. He completed an Internal Medicine residency at the University of Texas at Houston and Cardiology Fellowship training at the Texas Heart Institute. He practices cardiology in Orange County, California. Matt Coyle is the Anthony Award-winning author of the Rick Cahill crime series.

For this episode, DP Lyle, MD steps into the Interrogation Room to clear a few things up about murder. An Alabama native, Douglas earned his MD at the University of Alabama, completed a residency in Internal Medicine at the University of Texas at Houston, a Fellowship in Cardiology at The Texas Heart Institute, and has practiced cardiology in Orange County, California, for the past 40 years. Douglas is an Amazon #1 Bestseller and critically acclaimed nonfiction author with a dozen prestigious literary awards to his name. He writes four fiction series, as well as the ROYAL PAINS media tie-in novels. His essays and short stories appear in peer-reviewed and edited anthologies, and he's served as an editor and contributor for the Southern California Writers Association’s short story anthology, IT’S ALL IN THE STORY. Douglas has provided technical adviser to numerous novelists and screenwriters on more than a dozen popular television shows. He is also the creator and host of the podcast series CRIMINAL MISCHIEF: The Art and Science of Crime Fiction, and he co-hosted CRIME AND SCIENCE RADIO on SUSPENSE RADIO with Jan Burke. In this episode, Lyle and host Gavin Reese discuss his development as an author, writing three-dimensional medical professionals, and the time a convicted inmate mailed him 30 pages of crayon axe-murder crime scene drawings. Dp Lyle's Site: dplylemd.com Gavin’s works: www.amazon.com/Gavin-Reese/e/B072W5PPGS/ Gavin’s site: https://gavinreese.com #writersbeat #amwriting #amreading #amwritingfiction #thriller #espionage #writerslife #gavinthecop #gavinreese #police #policeprocedural #detective #conspiracy #conspiracyseries #writingcraft #nanowrimo #writingcoach #technicaladviser #technicaladvice #forensicsfordummies #dplylemd #dplyle #sunshinestate #jakelongly --- Support this podcast: https://anchor.fm/writersbeatpodcast/support

DP Lyle, MD is the Macavity and Benjamin Franklin Silver Award winning and Edgar, Agatha, Anthony, Scribe, Silver Falchion, and USA Best Book Award nominated author of many non-fiction books as well as numerous works of fiction, including the SAMANTHA CODY, DUB WALKER, and JAKE LONGLY thriller series and the ROYAL PAINS media tie-in novels. He has worked with many novelists and with the writers of popular television shows such as Law & Order, CSI: Miami, Diagnosis Murder, Monk, Judging Amy, Peacemakers, Cold Case, House, Medium, Women’s Murder Club, 1-800-Missing, The Glades, and Pretty Little Liars. He was born and raised in Huntsville, Alabama where his childhood interests revolved around football, baseball, and building rockets in his backyard. The latter pursuit was common in Huntsville during the 1950’s and 60’s due to the nearby NASA/Marshall Space Flight Center. After leaving Huntsville, he attended college, medical school, and served an internship at the University of Alabama; followed by a residency in Internal Medicine at the University of Texas at Houston; then a Fellowship in Cardiology at The Texas Heart Institute, also in Houston. For the past 35 years, he has practiced Cardiology in Orange County, California. Thorne and Cross’ new thriller, MOTHER, is available now. Visit Tamara and Alistair at their websites: tamarathorne.com and alistaircross.com This is a copyrighted, trademarked podcast owned solely by the Authors on the Air Global Radio

It's fifty years since the first human heart transplant but the number of donor organs - about 200 per year in the UK - remains dwarfed by demand. About 2,000 people under the age of 65 a year will die of heart failure without a transplant. Kevin Fong explores new ways that people with heart failure can be helped. He talks to Dr Doris Taylor, director of the Center for Cell and Organ Biotechnology, at the Texas Heart Institute, in Houston, about her research into growing hearts from stem cells. Kevin discusses the prospect of taking organs from pigs and using them for so-called xenotransplants with cardiothoracic surgeon Prof John Dark, of Newcastle University, who says this approach has not delivered benefits. An alternative to a heart transplant is the left ventricular assist device (LVAD) - an artificial pump that helps the left side of the heart do its job. This has shrunk from a large external piece of kit to a tiny battery-operated device that can be implanted into the chest. For the first year, they are as effective as a transplant, but they have a risk of infection, and they are not always easy to live with. Kevin meets patient Vincenzo Avanzato who had an LVAD that became infected and then a successful transplant. Kevin also talks to surgeon Mr Andre Simon of Harefield Hospital about the future of completely mechanical hearts made of metal and plastic.

DP Lyle, MD is the Macavity and Benjamin Franklin Silver Award winning and Edgar, Agatha, Anthony, Scribe, Silver Falchion, and USA Best Book Award nominated author of many non-fiction books as well as numerous works of fiction, including the SAMANTHA CODY, DUB WALKER, and JAKE LONGLY thriller series and the ROYAL PAINS media tie-in novels.  He has worked with many novelists and with the writers of popular television shows such as Law & Order, CSI: Miami, Diagnosis Murder, Monk, Judging Amy, Peacemakers, Cold Case, House, Medium, Women’s Murder Club, 1-800-Missing, The Glades, and Pretty Little Liars. He was born and raised in Huntsville, Alabama where his childhood interests revolved around football, baseball, and building rockets in his backyard. The latter pursuit was common in Huntsville during the 1950’s and 60’s due to the nearby NASA/Marshall Space Flight Center. After leaving Huntsville, he attended college, medical school, and served an internship at the University of Alabama; followed by a residency in Internal Medicine at the University of Texas at Houston; then a Fellowship in Cardiology at The Texas Heart Institute, also in Houston. For the past 35 years, he has practiced Cardiology in Orange County, California. Thorne and Cross’ new thriller, MOTHER, is available now. http:Visit Tamara and Alistair at their websites. This is a copyrighted, trademarked podcast owned solely by the Authors on the Air Global Radio  

People die each day waiting on lists for lifesaving organs, and the rise of chronic diseases such as diabetes only increases the demand. With the need for scientific innovation and donor support becoming ever more critical, this Forum explored biomedical advances that promise to address the scarcity, as well as the efforts of medical leaders, advocates and policymakers to reduce the numbers waiting for transplants. Through 3-D printing, scaffolding, chips and other innovations, scientists made extraordinary strides in tissue engineering and developing artificial organs. This program looked at the potential of advances like these, along with the ongoing role of current donation programs; ethics of matching and allocation policies; controversies around buying and selling organs; and approaches such as “presumed consent”, used in some countries to increase supply, where patients are presumed to have given permission to donate their organs, unless they have explicitly opted out. Part of The Dr. Lawrence H. and Roberta Cohn Forums, this event was presented May 20, 2016 in Collaboration with The Huffington Post and in Association with Harvard Health Publications. Watch the entire series from The Forum at Harvard T.H. Chan School of Public Health at www.ForumHSPH.org.

William E. Cohn, MD, is Director of the Center for Technology and Innovation; Associate Director of Laboratory Surgery Research in the Center for Cardiac Support; and Director of the Cullen Cardiovascular Research Laboratory at the Texas Heart Institute. He is also a professor of surgery at Baylor College of Medicine and an adjunct professor of bioengineering at both Rice University and the University of Houston. His major research interests include the development of new technology for decreasing the invasiveness of cardiac and vascular surgery and development of the continuous-flow totally implantable artificial heart.   In 2011, Dr. Cohn and Dr. O. H. Frazier successfully implanted the first pulseless total heart replacement device in a human patient. Dr. Cohn has a passion for medical device development and has more than 90 US patents granted or pending and another 60 international patents for his medical innovations. His numerous awards include an honorary doctorate in science from Oberlin College, the Distinguished Scientist Award, given by the MacDonald Fund, and the Edison Award for excellence in human-centered design and innovation for inventing the SentreHEART® Lariat® Suture Delivery Device.   In 2000, Dr. Cohn was named the distinguished Inventor of the Year by the U.S. Intellectual Property Owners Association and in 2014, he was named Outstanding Inventor of the Year by the Houston IPO. In addition, in 2014 he received an award for the most Innovative Medical Device Startup of the year at the Inn ovations in Cardiovascular Interventions Conference in Tel Aviv for inventing the TVA Everlinq syste m for percutaneous creation of AV fistulas and for founding TVA Medical.   In 2015, he was awarded a Lifetime Achievement Award for healthcare innovation by the Houston Technology Center. He is a Venture Partner at Sante Health Ventures, and Chief Medical Officer of BiVACOR Inc. and Reliant Heart. For more information visit http://cstem.org.

Auscultation of the murmur of congenital ventricular septal defect (VSD). Copyright 2011 by the Texas Heart Institute at St. Luke's Episcopal Hospital.

Auscultation of murmurs associated with hypertrophic obstructive cardiomyopathy (HOCM) and LV outlet obstruction. Copyright 2011 by the Texas Heart Institute at St. Luke's Episcopal Hospital.

Auscultation of a diastolic sound referred to as tumor plop, resulting from a left atrial myxoma. The sound arises from obstruction to ventricular in-flow. Copyright 2011 by the Texas Heart Institute at St. Luke's Episcopal Hospital.

The early diastolic sound of pericardial constriction occurs slightly earlier than the average third heart sound. Its frequency is somewhat higher, allowing you to hear it throughout the precordium using the diaphragm and the bell. Common causes of pericardial constriction include prior cardiac surgery and uremic pericarditis. Copyright 2011 by the Texas Heart Institute at St. Luke's Episcopal Hospital.

Auscultation of the fixed splitting of the second heart sound, a finding on physical examination very specific for atrial septal defect. Copyright 2010 by the Texas Heart Institute at St. Luke's Episcopal Hospital.

Auscultation of the wide splitting of the second heart sound, commonly caused by right bundle branch block (RBBB). Copyright 2010 by the Texas Heart Institute at St. Luke's Episcopal Hospital.

Auscultation of paradoxical splitting of the second sound, opposite of the normal or physiological finding. Copyright 2010 by the Texas Heart Institute at St. Luke's Episcopal Hospital.

Host: Janet Wright, MD Guest: Mohammad Madjid, MD When high-risk patients, such as the elderly, develop respiratory infections there can be a cascade effect of inflammation that moves from the lungs to the heart, triggering myocardial infarction (or MI). What is the mechanism by which vaccination might prevent MI? Dr. Mohammed Madjid, senior research scientist at Texas Heart Institute in Houston, explains the cause and effect relationship between the influenza and pneumococcal vaccines, and MI. What are the vaccine guideline recommendations for patients with heart disease, and can early use of antibiotics help reduce the risk of infection-related cardiovascular events? Dr. Janet Wright hosts. Produced in Cooperation with

Host: Janet Wright, MD Guest: Mohammad Madjid, MD When high-risk patients, such as the elderly, develop respiratory infections there can be a cascade effect of inflammation that moves from the lungs to the heart, triggering myocardial infarction (or MI). What is the mechanism by which vaccination might prevent MI? Dr. Mohammed Madjid, senior research scientist at Texas Heart Institute in Houston, explains the cause and effect relationship between the influenza and pneumococcal vaccines, and MI. What are the vaccine guideline recommendations for patients with heart disease, and can early use of antibiotics help reduce the risk of infection-related cardiovascular events? Dr. Janet Wright hosts. Produced in Cooperation with

Auscultation of physiological splitting of the second heart sound. Copyright 2010 by the Texas Heart Institute at St. Luke's Episcopal Hospital.

Guest: Denton Cooley, MD Host: Martin Samuels, MD In April, 1969, the first artificial heart was implanted as a bridge until a human heart could be implanted. It was hailed as a milestone medical treatment, but the ethical implications were widely debated as well. The heart surgeon who performed this ground-breaking surgery, in addition to devising pioneering surgical treatments for infants and children and founding the Texas Heart Institute, Dr. Denton Cooley, is Dr. Martin Samuels' guest.

Auscultation of tricuspid insufficiency and its resulting regurgitation. Copyright 2010 by the Texas Heart Institute at St. Luke's Episcopal Hospital.

This podcast presents auscultation of the fourth heart sound (S4). Copyright 2010 by the Texas Heart Institute at St. Luke's Episcopal Hospital.

This podcast presents auscultation of the third heart sound (s3). Copyright 2009 by the Texas Heart Institute at St. Luke's Episcopal Hospital.

This podcast presents auscultation of opening snap of mitral valve stenosis. Copyright 2009 by the Texas Heart Institute at St. Luke's Episcopal Hospital.

Texas Heart Institute presents auscultation of mitral valve stenosis. Copyright 2009 by the Texas Heart Institute at St. Luke's Episcopal Hospital.

Texas Heart Institute presents auscultation of acute mitral regurgitation due to flail posterior leaflet. Copyright 2009 by the Texas Heart Institute at St. Luke's Episcopal Hospital.

Texas Heart Institute presents auscultation of mitral regurgitation. Copyright 2009 by the Texas Heart Institute at St. Luke's Episcopal Hospital.

Texas Heart Institute presents the Austin Flint murmur (rumble) of aortic insufficiency. Copyright 2009 by the Texas Heart Institute at St. Luke's Episcopal Hospital.

Texas Heart Institute presents auscultation of chronic severe aortic valve insufficiency and its decrescendo murmur. Copyright 2009 Texas Heart Institute.

Texas Heart Institute presents auscultation of the heart sounds associated with aortic stenosis. Copyright 2009 Texas Heart Institute.

Texas Heart Institute presents auscultation of the heart sounds associated with pulmonary valve ejection. An ejection sound is the audible component of achieving peak ejection blood flow velocity. Copyright 2009 Texas Heart Institute.

Texas Heart Institute presents auscultation of the heart sounds associated with aortic valve ejection. An ejection sound is the audible component of achieving peak ejection blood flow velocity. Copyright 2009 Texas Heart Institute.

An examination of the heart sounds associated with midsystolic click. Midsystolic click is virtually synonymous with prolapse of the mitral valve toward the left atrium during systole.